TipHub

₹23.2

▼ -1.22 -5.00%

As of 27 Jul 2026 · delayed

BSE Listed

GSM · GSM 4
What does GSM · GSM 4 mean?
BSE · Graded Surveillance Measure (GSM 4)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).Exchange notice · 2026-06-05

Hemo Organic Limited (524590)

Volume: 100Avg Vol 1W: 23,144Avg Vol 1M: 18,55752W Range:₹8.08₹24.42
BSE www.hemoorganic.com AI Report
Key Ratios
Checked 1h ago
Market Cap₹8 Cr
Current Price₹23.2
Previous Close₹24.42
High / Low (52w)₹24.42 / ₹8.08
Volume100
Avg Vol (1W)23,144
Avg Vol (1M)18,557
Stock P/E—
Book Value₹-2.7
Dividend Yield0%
ROE-585.48%
ROA-17.26%
Revenue (TTM)—
Revenue Growth—
Profit Margin-82.8%
Total Debt—
Shares Outstanding0 Cr
Face Value—
EPS (TTM)₹0
P/B—
Debt / Equity0
50 DMA₹15.82
200 DMA₹13.61
Day change-5.00%
SurveillanceGSM · GSM 4
Price Chart
₹23.2▲ 158.93% · 1Y
₹24₹81.5L
2025-07-29
2026-07-27

20-day avg volume: 20K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 10892% YoY.
Cons
  • Negative book value per share.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹0 Cr₹0 Cr₹2 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS-0.43-0.35-0.06-0.14-0.18-0.16-0.760.47
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹5 Cr
Total Liabilities₹1 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹5 Cr
Equity₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr
Shareholding
Promoter 16.85% Institutions 0% Public 83.15%
Efficiency & Working Capital
ROCE-17.3%
Interest Coverage0
Dividend Payout—
Debtor Days381 d
Inventory Days214 d
Payable Days549 d
Cash Conversion Cycle46 d
Working Capital Days595 d
Shareholding Details

As of 2026-06-30

Promoter16.8%
FII0%
DII0%
Institutions0%
Public83.2%
Promoter Pledge0%
No. of Shareholders4,821
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters16.8%16.8%16.8%16.8%16.8%16.8%16.8%16.8%16.8%16.8%16.8%16.8%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public83.2%83.2%83.2%83.2%83.2%83.2%83.2%83.2%83.2%83.2%83.2%83.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders5,6775,3805,1784,9024,7745,0485,2185,2125,2135,0554,9884,821
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Dineshbhai Shanabhai PatelShareholding of Promoter and Promoter Group15.5%5,36,940
Mitalben Rupeshbhai DesaiPublic Shareholding3.5%1,21,002
Rupesh Ramanlal DesaiPublic Shareholding3.5%1,20,795
Mansukhlal Chhotalal ShahPublic Shareholding2.5%87,044
Ruchira GoyalPublic Shareholding2.1%73,000
Rajput VishalPublic Shareholding1.8%61,650
Sagar ShethPublic Shareholding1.8%61,609
Vijay Bhikhabhai ShethPublic Shareholding1.7%59,651
Sangitaben Vijaykuamr ShethPublic Shareholding1.7%59,345
Dave Pradip BharatbhaiPublic Shareholding1.7%57,204
Ayush Dharmendrabhai JasaniPublic Shareholding1.6%54,689
Mohammed FasihuddinPublic Shareholding1.5%52,144
Manish Hasmukhbhai DhakechaPublic Shareholding1.4%49,836
Sonalben Dineshbhai PatelShareholding of Promoter and Promoter Group1.4%47,000
Hitendra Chunilal PrajapatiPublic Shareholding1%35,485
Board of Directors
NameDesignationYear
Murlidhar JoshiNon Executive Director / Chief Financial Officer2025
Hiral Vinodbhai PatelIndependent Non Exe. Director2025
Rina KumariIndependent Non Exe. Director2025
VISHWAMBAR KAMESHWAR SINGHManaging Director2025
Deepak Ashokkumar RochaniIndependent Non Exe. Director2025
Yukta Prakash PatelCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10433
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-15Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000000
2025000000
2025000000
Company Information
Incorporated1992
AuditorM A A K & Associates
Investor Email[email protected]
🌐 www.hemoorganic.com ↗

📍 Shop 1 to 3 First Flr, Piyu Apartment Nikol Gam Road, Ahmedabad, Gujarat, 382350

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Gayatri Bioorganics Ltd.Poddar PigmentsPharmaids Pharmaceuticals Ltd.Vivid Global Industries LimitedPriya Ltd.Tirupati Starch & Chemicals Ltd.Jaysynth Orgochem LimitedAeonx Digital Technology Ltd.AksharChemBandaram Pharma Packtech Ltd.Adline Chem Lab LimitedBeryl Drugs Ltd.All “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search